Post Inflammatory Hyperpigmentation Completed Phase Trials for Clobetasol propionate (DB01013)

Also known as: Postinflammatory Hyperpigmentation / Post-inflammatory Hyperpigmentation / Postinflammatory hyperpigmentation (morphologic abnormality) / Post-inflammatory hyperpigmentation (disorder) / Post inflammatory pigmentation change

IndicationStatusPhase
DBCOND0045798 (Post Inflammatory Hyperpigmentation)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02492373Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG LaserTreatment